Sign Out
Posology: Adults: The recommended and maximum dose is one inhalation of TRELEGY ELLIPTA 92/55/22 micrograms once daily, at the same time each day.
If a dose is missed the next dose should be inhaled at the usual time the next day.
Special populations: Elderly patients: No dose adjustment is required in patients over 65 years (see Pharmacology: Pharmacokinetics under Actions).
Renal impairment: No dose adjustment is required in patients with renal impairment (see Pharmacology: Pharmacokinetics under Actions).
Hepatic impairment: No dose adjustment is required in patients with mild, moderate or severe hepatic impairment. TRELEGY ELLIPTA should be used with caution in patients with moderate to severe hepatic impairment (see Precautions and Pharmacology: Pharmacokinetics under Actions).
Paediatric population: There is no relevant use of TRELEGY ELLIPTA in the paediatric population (under 18 years of age) for the indication of COPD.
Method of administration: TRELEGY ELLIPTA is for inhalation use only.
